ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.298,09
0,69%
S&P 500
5.180,74
0,00%
Dow Jones
38.852,27
0,00%
Euro vs US Dollar
1,07788
0,11%
Bitcoin
63.674,64
0,80%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Personalis Inc (PSNL)

  7. Personalis Inc (PSNL) News

PSNL Personalis Inc

1,59
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 10:00:00
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Personalis Inc PSNL NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,00 0,00% 1,59 10:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,59
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
24.4.202422:01BWPersonalis to Announce First Quarter 2024 Financial Results
28.3.202421:01BWPersonalis to Present at the 23rd Annual Needham Virtual..
28.3.202414:00BWData Showcasing NeXT Personal MRD Test to be Presented at..
26.3.202414:00BWPersonalis Announces Publication Validating NeXT Personal®..
19.3.202421:43BWPersonalis Announces Inducement Grants Under Nasdaq Listing..
28.2.202422:01BWPersonalis Reports Fourth Quarter and Full Year 2023..
28.2.202422:00EDGAR2Form 8-K - Current report
14.2.202422:01BWPersonalis to Announce Fourth Quarter and Full Year 2023..
31.1.202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.1.202422:01BWPersonalis to Participate at Upcoming Investor Conferences
30.1.202415:00BWPersonalis and ClearNote Health Announce Partnership to..
29.1.202422:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
17.1.202422:15BWPersonalis Announces Inducement Grants Under Nasdaq Listing..
16.1.202415:05BWPersonalis Announces Medicare Coverage for NeXT Dx(R)..
10.1.202406:15EDGAR2Form EFFECT - Notice of Effectiveness
05.1.202415:09EDGAR2Form 8-K - Current report
05.1.202415:05BWPersonalis Reports Preliminary Fourth Quarter and Full Year..
21.12.202323:15EDGAR2Form S-3 - Registration statement under Securities Act of..
21.12.202323:12EDGAR2Form S-3 - Registration statement under Securities Act of..
20.12.202300:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.12.202300:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.12.202322:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04.12.202315:15BWPersonalis Extends Cash Position Into 2026, Provides Update..
01.12.202322:51EDGAR2Form 8-K - Current report
28.11.202322:58EDGAR2Form 8-K - Current report
28.11.202322:15BWPersonalis and Tempus Enter into a Strategic Collaboration..
20.11.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.11.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.11.202322:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.11.202322:01BWPersonalis Reports Third Quarter 2023 Financial Results
07.11.202322:00EDGAR2Form 8-K - Current report
26.10.202314:15BWPersonalis Launches NeXT Personal® Dx for Early Access..
24.10.202322:01BWPersonalis to Announce Third Quarter 2023 Financial Results
21.10.202310:25BWAnalysis from TRACERx Study Reveals More Sensitive and..
19.10.202313:15BWPersonalis Announces Late-Breaking NeXT Personal Abstract..
18.10.202313:15BWPersonalis Appoints Former Roche Diagnostics and GRAIL..
29.8.202322:01BWPersonalis to Present at the 21st Annual Morgan Stanley..
28.8.202323:11EDGAR2Form 8-K - Current report
25.8.202301:01BWPersonalis Announces Inducement Grants Under Nasdaq Listing..
08.8.202322:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.8.202322:01EDGAR2Form 8-K - Current report
08.8.202322:01BWPersonalis Reports Second Quarter 2023 Financial Results
02.8.202322:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.8.202322:01BWPersonalis to Participate at Upcoming Investor Conferences
25.7.202322:01BWPersonalis to Announce Second Quarter 2023 Financial Results
26.6.202323:00BWPersonalis Files Second Patent Infringement Suit Against..
14.6.202301:01BWDr. Kenneth J. Widder Joins Personalis Board of Directors
30.5.202314:00BWPersonalis Announces Two Abstracts Accepted for Presentation..
16.5.202322:19BWPersonalis、国立がん研究センター東病院、小野薬品が提携、直腸がん免疫療法反応の予測向上へ
16.5.202314:00BWPersonalis, National Cancer Center Hospital East, and Ono..

Kürzlich von Ihnen besucht

NASDAQ
PSNL
Personalis
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten